AUC72 [Design Issues]

posted by jag009  – NJ, 2012-05-10 17:15 (5144 d 23:54 ago) – Posting: # 8554
Views: 5,581

Thanks everyone,

One question regarding the truncated AUC 0-72 hrs. Is it applicable only for generic filing or it also applies to supplemental NDA filing? ie, changing from a Tablet to a Capsule (same strength, same indication), from capsule to a tablet, dosage strength proportionality studies?

John

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
125 visitors (0 registered, 125 guests [including 20 identified bots]).
Forum time: 17:10 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5